Guideline document
This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.
Hodgkin Lymphoma PDQ®
Topic overview
Evidence-based clinical reference from the National Cancer Institute for healthcare professionals managing childhood Hodgkin lymphoma. Provides current treatment protocols, risk stratification approaches, and therapeutic strategies for this pediatric hematologic malignancy.
Key Takeaways
- Hodgkin lymphoma is a highly curable pediatric malignancy with distinct treatment protocols for children versus adults.
- Risk-adapted therapy balances cure rates with minimizing long-term toxicities including secondary malignancies and cardiac disease.
- PET-CT imaging is critical for staging and response assessment to guide treatment intensity.
- Combined modality therapy (chemotherapy + radiation) remains standard, though radiation doses have been reduced to limit late effects.
- Long-term survivorship care is essential given risks of secondary cancers, cardiovascular disease, and endocrine dysfunction.
Keywords
Hashtags
Full guideline text
Full text not available for this guideline
How to cite: GlobalCastMD. Hodgkin Lymphoma PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2379
Comments